Full Press Release Details
IDEAYA Biosciences Announces First Patient In for Phase 1 Clinical Trial Evaluating IDE397 and Trodelvy R Combination in MTAP Deletion Bladder Cancer.
IDYA
IDEAYA Biosciences Announces First Patient In for Phase 1 Clinical Trial Evaluating IDE397 and Trodelvy R Combination in MTAP Deletion Bladder Cancer
Key Takeaway: IDEAYA Biosciences Announces First Patient In for Phase 1 Clinical Trial Evaluating IDE397 and Trodelvy R Combination in MTAP Deletion Bladder Cancer